Calling Night-Time Episodes Of Low Blood Sugar 'Non-Severe' Is A 'Serious Misnomer' Say Researchers Who Uncovered Their High Cost

Published Nov 27, 2013
Copenhagen, Denmark - A new, international study published in Value in Health reveals the high economic and personal cost of seemingly non-severe episodes of hypoglycaemia (low blood sugar) suffered by people with diabetes at night while sleeping. According to the study, each non-severe nocturnal hypoglycaemic event (NSNHE) costs $127.00 per person, per episode, as a result of lost work productivity and health care use, and hence the study authors say the non-severe label is a ‘serious misnomer’. NSNHEs are so called because they do not require immediate medical attention or help from anyone else, however, they disrupt sleep and can affect functioning and wellbeing the next day. The study surveyed 2,108 people with type 1 and type 2 diabetes in nine countries in Europe and North America to evaluate the economic impact of these events in terms of lost work productivity and health care use (e.g., use of extra blood sugar tests and contacts with health care professionals). “Given these findings, we cannot ignore the serious consequences of so-called non-severe night-time episodes of hypoglycaemia on patients and the economy. We should consider treatments that can reduce night-time hypoglycaemia,” said lead investigator Meryl Brod, PhD, President, The Brod Group. The full study, “Understanding the Economic Burden of Nonsevere Nocturnal Hypoglycemic Events: Impact on Work Productivity, Disease Management, and Resource Utilization,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.

Advancing the Economics of Mental Health: A Global Perspective

Mar 12, 2025

Value in Health, the official journal of ISPOR announced the publication of a special themed section of research papers exploring mental health economics, highlighting impacts on caregivers, productivity, and interventions’ cost-effectiveness.

Generative AI Set to Reshape Health Technology Assessment, ISPOR Report Finds

Feb 11, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of an ISPOR Working Group Report that provides an introduction to the uses of generative artificial intelligence (AI) in health technology assessment (HTA).
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×